Autoimmune movement disorders

Andrew B McKeon, Angela Vincent

Research output: Chapter in Book/Report/Conference proceedingConference contribution

8 Citations (Scopus)

Abstract

Autoimmune movement disorders encapsulate a large and diverse group of neurologic disorders occurring either in isolation or accompanying more diffuse autoimmune encephalitic illnesses. The full range of movement phenomena has been described and, as they often occur in adults, many of the presentations can mimic neurodegenerative disorders, such as Huntington disease. Disorders may be ataxic, hypokinetic (parkinsonism), or hyperkinetic (myoclonus, chorea, tics, and other dyskinetic disorders). The autoantibody targets are diverse and include neuronal surface proteins such as leucine-rich, glioma-inactivated 1 (LGI1) and glycine receptors, as well as antibodies (such as intracellular antigens) that are markers of a central nervous system process mediated by CD8. + cytotoxic T cells. However, there are two conditions, stiff-person syndrome (also known as stiff-man syndrome) and progressive encephalomyelitis with rigidity and myoclonus (PERM), that are always autoimmune movement disorders. In some instances (such as Purkinje cell cytoplasmic antibody-1 (PCA-1) autoimmunity), antibodies detected in serum and cerebrospinal fluid can be indicative of a paraneoplastic cause, and may direct the cancer search. In other instances (such as 65 kDa isoform of glutamic acid decarboxylase (GAD65) autoimmunity), a paraneoplastic cause is very unlikely, and early treatment with immunotherapy may promote improvement or recovery. Here we describe the different types of movement disorder and the clinical features and antibodies associated with them, and discuss treatment.

Original languageEnglish (US)
Title of host publicationAutoimmune Neurology, 2016
PublisherElsevier
Pages301-315
Number of pages15
Volume133
ISBN (Print)9780444634320
DOIs
StatePublished - 2016

Publication series

NameHandbook of Clinical Neurology
Volume133
ISSN (Print)00729752
ISSN (Electronic)22124152

Fingerprint

Movement Disorders
Stiff-Person Syndrome
Myoclonus
Antibodies
Autoimmunity
Glycine Receptors
Tics
Chorea
Glutamate Decarboxylase
Purkinje Cells
Huntington Disease
Differentiation Antigens
Parkinsonian Disorders
Nervous System Diseases
Leucine
Glioma
Neurodegenerative Diseases
Autoantibodies
Immunotherapy
Cerebrospinal Fluid

Keywords

  • Autoimmune
  • Chorea
  • Myoclonus
  • PERM
  • Stiff-person

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

McKeon, A. B., & Vincent, A. (2016). Autoimmune movement disorders. In Autoimmune Neurology, 2016 (Vol. 133, pp. 301-315). (Handbook of Clinical Neurology; Vol. 133). Elsevier. https://doi.org/10.1016/B978-0-444-63432-0.00017-7

Autoimmune movement disorders. / McKeon, Andrew B; Vincent, Angela.

Autoimmune Neurology, 2016. Vol. 133 Elsevier, 2016. p. 301-315 (Handbook of Clinical Neurology; Vol. 133).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

McKeon, AB & Vincent, A 2016, Autoimmune movement disorders. in Autoimmune Neurology, 2016. vol. 133, Handbook of Clinical Neurology, vol. 133, Elsevier, pp. 301-315. https://doi.org/10.1016/B978-0-444-63432-0.00017-7
McKeon AB, Vincent A. Autoimmune movement disorders. In Autoimmune Neurology, 2016. Vol. 133. Elsevier. 2016. p. 301-315. (Handbook of Clinical Neurology). https://doi.org/10.1016/B978-0-444-63432-0.00017-7
McKeon, Andrew B ; Vincent, Angela. / Autoimmune movement disorders. Autoimmune Neurology, 2016. Vol. 133 Elsevier, 2016. pp. 301-315 (Handbook of Clinical Neurology).
@inproceedings{f40e5444892e4a399b3d09ee849522e5,
title = "Autoimmune movement disorders",
abstract = "Autoimmune movement disorders encapsulate a large and diverse group of neurologic disorders occurring either in isolation or accompanying more diffuse autoimmune encephalitic illnesses. The full range of movement phenomena has been described and, as they often occur in adults, many of the presentations can mimic neurodegenerative disorders, such as Huntington disease. Disorders may be ataxic, hypokinetic (parkinsonism), or hyperkinetic (myoclonus, chorea, tics, and other dyskinetic disorders). The autoantibody targets are diverse and include neuronal surface proteins such as leucine-rich, glioma-inactivated 1 (LGI1) and glycine receptors, as well as antibodies (such as intracellular antigens) that are markers of a central nervous system process mediated by CD8. + cytotoxic T cells. However, there are two conditions, stiff-person syndrome (also known as stiff-man syndrome) and progressive encephalomyelitis with rigidity and myoclonus (PERM), that are always autoimmune movement disorders. In some instances (such as Purkinje cell cytoplasmic antibody-1 (PCA-1) autoimmunity), antibodies detected in serum and cerebrospinal fluid can be indicative of a paraneoplastic cause, and may direct the cancer search. In other instances (such as 65 kDa isoform of glutamic acid decarboxylase (GAD65) autoimmunity), a paraneoplastic cause is very unlikely, and early treatment with immunotherapy may promote improvement or recovery. Here we describe the different types of movement disorder and the clinical features and antibodies associated with them, and discuss treatment.",
keywords = "Autoimmune, Chorea, Myoclonus, PERM, Stiff-person",
author = "McKeon, {Andrew B} and Angela Vincent",
year = "2016",
doi = "10.1016/B978-0-444-63432-0.00017-7",
language = "English (US)",
isbn = "9780444634320",
volume = "133",
series = "Handbook of Clinical Neurology",
publisher = "Elsevier",
pages = "301--315",
booktitle = "Autoimmune Neurology, 2016",

}

TY - GEN

T1 - Autoimmune movement disorders

AU - McKeon, Andrew B

AU - Vincent, Angela

PY - 2016

Y1 - 2016

N2 - Autoimmune movement disorders encapsulate a large and diverse group of neurologic disorders occurring either in isolation or accompanying more diffuse autoimmune encephalitic illnesses. The full range of movement phenomena has been described and, as they often occur in adults, many of the presentations can mimic neurodegenerative disorders, such as Huntington disease. Disorders may be ataxic, hypokinetic (parkinsonism), or hyperkinetic (myoclonus, chorea, tics, and other dyskinetic disorders). The autoantibody targets are diverse and include neuronal surface proteins such as leucine-rich, glioma-inactivated 1 (LGI1) and glycine receptors, as well as antibodies (such as intracellular antigens) that are markers of a central nervous system process mediated by CD8. + cytotoxic T cells. However, there are two conditions, stiff-person syndrome (also known as stiff-man syndrome) and progressive encephalomyelitis with rigidity and myoclonus (PERM), that are always autoimmune movement disorders. In some instances (such as Purkinje cell cytoplasmic antibody-1 (PCA-1) autoimmunity), antibodies detected in serum and cerebrospinal fluid can be indicative of a paraneoplastic cause, and may direct the cancer search. In other instances (such as 65 kDa isoform of glutamic acid decarboxylase (GAD65) autoimmunity), a paraneoplastic cause is very unlikely, and early treatment with immunotherapy may promote improvement or recovery. Here we describe the different types of movement disorder and the clinical features and antibodies associated with them, and discuss treatment.

AB - Autoimmune movement disorders encapsulate a large and diverse group of neurologic disorders occurring either in isolation or accompanying more diffuse autoimmune encephalitic illnesses. The full range of movement phenomena has been described and, as they often occur in adults, many of the presentations can mimic neurodegenerative disorders, such as Huntington disease. Disorders may be ataxic, hypokinetic (parkinsonism), or hyperkinetic (myoclonus, chorea, tics, and other dyskinetic disorders). The autoantibody targets are diverse and include neuronal surface proteins such as leucine-rich, glioma-inactivated 1 (LGI1) and glycine receptors, as well as antibodies (such as intracellular antigens) that are markers of a central nervous system process mediated by CD8. + cytotoxic T cells. However, there are two conditions, stiff-person syndrome (also known as stiff-man syndrome) and progressive encephalomyelitis with rigidity and myoclonus (PERM), that are always autoimmune movement disorders. In some instances (such as Purkinje cell cytoplasmic antibody-1 (PCA-1) autoimmunity), antibodies detected in serum and cerebrospinal fluid can be indicative of a paraneoplastic cause, and may direct the cancer search. In other instances (such as 65 kDa isoform of glutamic acid decarboxylase (GAD65) autoimmunity), a paraneoplastic cause is very unlikely, and early treatment with immunotherapy may promote improvement or recovery. Here we describe the different types of movement disorder and the clinical features and antibodies associated with them, and discuss treatment.

KW - Autoimmune

KW - Chorea

KW - Myoclonus

KW - PERM

KW - Stiff-person

UR - http://www.scopus.com/inward/record.url?scp=84978437471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978437471&partnerID=8YFLogxK

U2 - 10.1016/B978-0-444-63432-0.00017-7

DO - 10.1016/B978-0-444-63432-0.00017-7

M3 - Conference contribution

C2 - 27112684

AN - SCOPUS:84978437471

SN - 9780444634320

VL - 133

T3 - Handbook of Clinical Neurology

SP - 301

EP - 315

BT - Autoimmune Neurology, 2016

PB - Elsevier

ER -